Vaccination

This is how WHO is ensuring equal international access to a COVID-19 vaccine

COVAX aims to deliver 2 billion doses of effective, approved COVID-19 vaccines by the end of 2021. Image: REUTERS/Agustin Marcarian

Carl O'Donnell

Reporter , Reuters

Share:

Our Impact
The Big Picture
Explore and monitor how Vaccination is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Vaccination

A woman holds a small bottle labeled with a
COVAX is working to ensure fair access to COVID-19 vaccines. Image: Reuters/Dado Ruvic/Illustration

Have you read?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

VaccinationCOVID-19Pandemic Preparedness and ResponseGlobal HealthGlobal Governance

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Research reveals the links between viruses and Alzheimer's disease

Ruth Itzhaki

November 24, 2022

About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum